πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 140 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10471051

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

Asana BioSciences, LLC Β· Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10441646

Infectious plasmodium sporozoites grown in vitro

Sanaria Inc. Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10368569

Natural sweetener

MONTERO GIDA SANAYI VE TICARET A.S. Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10316039

P2X3 and/or P2X2/3 compounds and methods

Asana BioSciences, LLC Β· Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10316080

Protein-polymer-drug conjugates

Asana BioSciences, LLC Β· Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10272146

Purified plasmodium and vaccine compositions

Sanaria Inc. Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226468

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/m

Asana BioSciences, LLC Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226535

Auristatin compounds and conjugates thereof

Mersana Therapeutics, Inc. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10188654

Uses of pyrimido-pyridazinones to treat cancer

Asana BioSciences, LLC Β· Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10183944

Pyrimido-pyridazinone compounds and methods of use thereof

Asana BioSciences, LLC Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10174039

P2X3 and/or P2X2/3 compounds and methods

Asana BioSciences, LLC Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10143695

Pyrrolobenzodiazepines and conjugates thereof

Mersana Therapeutics, Inc. Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10130618

Pharmaceutical combinations of dabigatran and proton pump inhibitors

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10111925

Formulations comprising plant extracts

MONTERO GIDA SANAYI VE TICARET A.S. Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10111912

Herbal formulations

MONTERO GIDA SANAYI VE TICARET A.S. Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10111957

Inhalation compositions comprising glucose anhydrous

ARVEN ILAC SANAYI VE TICARET A.S. Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10105316

Inhalation compositions comprising muscarinic receptor antagonist

ARVEN ILAC SANAYI VE TICARET A.S. Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9980931

Use of glycyl glutamine against depression

Uludag Universitesi Teknoloji Transfer Ofisi Ticaret Ve Sanayi Anonim Suirketi Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9944637

P2X3 and/or P2X2/3 compounds and methods

Asana BioSciences, LLC Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9943609

Protein-polymer-drug conjugates

Mersana Therapeutics, Inc. Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9931389

Genetic attenuation of plasmodium by B9 gene disruption

Sanaria Inc. Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9913869

Formulations comprising herbal extracts

MONTERO GIDA SANAYI VE TICARET A.S. Β· Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9908879

P2X3 and/or P2X2/3 compounds and methods

Asana BioSciences, LLC Β· Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9896445

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

Ansana BioSciences, LLC Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted